Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Total Long-Term Assets 2010-2024 | VRTX

Vertex Pharmaceuticals total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Vertex Pharmaceuticals total long-term assets for the quarter ending September 30, 2024 were $12.436B, a 76.89% increase year-over-year.
  • Vertex Pharmaceuticals total long-term assets for 2023 were $8.586B, a 74.65% increase from 2022.
  • Vertex Pharmaceuticals total long-term assets for 2022 were $4.916B, a 26.97% increase from 2021.
  • Vertex Pharmaceuticals total long-term assets for 2021 were $3.872B, a 7.01% increase from 2020.
  
Vertex Pharmaceuticals Annual Total Long-Term Assets
(Millions of US $)
2023 $8,586
2022 $4,916
2021 $3,872
2020 $3,618
2019 $3,496
2018 $2,403
2017 $897
2016 $1,065
2015 $1,091
2014 $788
2013 $730
2012 $1,170
2011 $873
2010 $668
2009 $648
Vertex Pharmaceuticals Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $12,436
2024-06-30 $11,191
2024-03-31 $10,629
2023-12-31 $8,586
2023-09-30 $7,030
2023-06-30 $6,476
2023-03-31 $6,009
2022-12-31 $4,916
2022-09-30 $4,435
2022-06-30 $4,079
2022-03-31 $3,895
2021-12-31 $3,872
2021-09-30 $3,766
2021-06-30 $3,764
2021-03-31 $3,576
2020-12-31 $3,618
2020-09-30 $3,843
2020-06-30 $3,522
2020-03-31 $3,447
2019-12-31 $3,496
2019-09-30 $2,737
2019-06-30 $2,323
2019-03-31 $2,360
2018-12-31 $2,403
2018-09-30 $934
2018-06-30 $928
2018-03-31 $912
2017-12-31 $897
2017-09-30 $870
2017-06-30 $1,105
2017-03-31 $1,075
2016-12-31 $1,065
2016-09-30 $1,108
2016-06-30 $1,095
2016-03-31 $1,085
2015-12-31 $1,091
2015-09-30 $1,075
2015-06-30 $1,079
2015-03-31 $808
2014-12-31 $788
2014-09-30 $756
2014-06-30 $770
2014-03-31 $767
2013-12-31 $730
2013-09-30 $934
2013-06-30 $868
2013-03-31 $826
2012-12-31 $1,170
2012-09-30 $1,084
2012-06-30 $1,012
2012-03-31 $910
2011-12-31 $873
2011-09-30 $846
2011-06-30 $936
2011-03-31 $666
2010-12-31 $668
2010-09-30 $662
2010-06-30 $650
2010-03-31 $644
2009-12-31 $648
2009-09-30 $659
2009-06-30 $657
2009-03-31 $664
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $133.076B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $174.849B 16.92
Gilead Sciences (GILD) United States $120.223B 21.80
Bristol Myers Squibb (BMY) United States $109.806B 46.27
Regeneron Pharmaceuticals (REGN) United States $91.035B 20.72
CSL (CSLLY) Australia $90.547B 0.00
GSK (GSK) United Kingdom $75.213B 8.70
Alnylam Pharmaceuticals (ALNY) United States $35.783B 0.00
Argenex SE (ARGX) Netherlands $35.638B 0.00
BioNTech SE (BNTX) Germany $26.306B 0.00
Biogen (BIIB) United States $25.215B 10.83
Illumina (ILMN) United States $23.963B 87.34
BeiGene (BGNE) Cayman Islands $20.001B 0.00
Moderna (MRNA) United States $18.001B 0.00
Incyte (INCY) United States $16.063B 0.00
Genmab (GMAB) Denmark $15.274B 22.41
Vaxcyte (PCVX) United States $13.295B 0.00
Insmed (INSM) United States $13.157B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.782B 29.68
Bio-Techne Corp (TECH) United States $12.069B 46.60
Sarepta Therapeutics (SRPT) United States $11.616B 104.84
Exelixis (EXEL) United States $10.352B 23.54
Revolution Medicines (RVMD) United States $10.167B 0.00
QIAGEN (QGEN) Netherlands $9.986B 20.54
Intra-Cellular Therapies (ITCI) United States $9.678B 0.00
Exact Sciences (EXAS) United States $9.528B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.375B 31.86
Roivant Sciences (ROIV) United Kingdom $8.778B 0.00
Repligen (RGEN) United States $7.880B 120.26
Halozyme Therapeutics (HALO) United States $7.758B 17.52
Viking Therapeutics (VKTX) United States $7.631B 0.00
Ascendis Pharma (ASND) Denmark $7.540B 0.00
Legend Biotech (LEGN) United States $7.298B 0.00
Cytokinetics (CYTK) United States $6.822B 0.00
Blueprint Medicines (BPMC) United States $6.405B 0.00
Nuvalent (NUVL) United States $6.183B 0.00
Krystal Biotech (KRYS) United States $5.741B 95.05
Arcellx (ACLX) United States $5.540B 0.00
ADMA Biologics Inc (ADMA) United States $5.272B 56.55
Avidity Biosciences (RNA) United States $5.130B 0.00
Biohaven (BHVN) United States $5.055B 0.00
Alkermes (ALKS) Ireland $4.670B 15.68
Ultragenyx Pharmaceutical (RARE) United States $4.650B 0.00
Denali Therapeutics (DNLI) United States $4.512B 0.00
Immunovant (IMVT) United States $4.486B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.406B 0.00
Axsome Therapeutics (AXSM) United States $4.278B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.138B 0.00
ImmunityBio (IBRX) United States $3.880B 0.00
Merus (MRUS) Netherlands $3.731B 0.00
Apellis Pharmaceuticals (APLS) United States $3.729B 0.00
Guardant Health (GH) United States $3.535B 0.00
Edgewise Therapeutics (EWTX) United States $3.411B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.409B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.308B 0.00
Kymera Therapeutics (KYMR) United States $3.300B 0.00
Amicus Therapeutics (FOLD) United States $3.284B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.134B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.129B 0.00
Zai Lab (ZLAB) China $3.050B 0.00
Iovance Biotherapeutics (IOVA) United States $2.962B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.929B 22.64
Janux Therapeutics (JANX) United States $2.830B 0.00
Apogee Therapeutics (APGE) United States $2.750B 0.00
Protagonist Therapeutics (PTGX) United States $2.723B 17.38
IDEAYA Biosciences (IDYA) United States $2.704B 0.00
CG Oncology (CGON) United States $2.679B 0.00
Twist Bioscience (TWST) United States $2.660B 0.00
Vericel (VCEL) United States $2.648B 900.00
Vera Therapeutics (VERA) United States $2.637B 0.00
Geron (GERN) United States $2.562B 0.00
Keros Therapeutics (KROS) United States $2.548B 0.00
SpringWorks Therapeutics (SWTX) United States $2.525B 0.00
Belite Bio (BLTE) United States $2.482B 0.00
Akero Therapeutics (AKRO) United States $2.392B 0.00
Scholar Rock Holding (SRRK) United States $2.327B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.327B 0.00
Bavarian Nordic (BVNRY) Denmark $2.324B 12.44
Beam Therapeutics (BEAM) United States $2.241B 0.00
Ligand Pharmaceuticals (LGND) United States $2.215B 57.19
Structure Therapeutics (GPCR) United States $2.175B 0.00
Neumora Therapeutics (NMRA) United States $2.167B 0.00
Fortrea Holdings (FTRE) United States $2.106B 67.14
Harmony Biosciences Holdings (HRMY) United States $2.058B 17.10
WAVE Life Sciences (WVE) Singapore $2.051B 0.00
NeoGenomics (NEO) United States $2.024B 0.00
MannKind (MNKD) United States $2.020B 52.46
Spyre Therapeutics (SYRE) United States $2.015B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.004B 0.00
Nurix Therapeutics (NRIX) United States $1.937B 0.00
Disc Medicine (IRON) United States $1.932B 0.00
NovoCure (NVCR) Jersey $1.887B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.880B 0.00
Arvinas (ARVN) United States $1.865B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.862B 0.00
Galapagos (GLPG) Belgium $1.783B 0.00
Certara (CERT) United States $1.776B 50.14
Celldex Therapeutics (CLDX) United States $1.740B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.735B 0.00
Dynavax Technologies (DVAX) United States $1.705B 100.08
Intellia Therapeutics (NTLA) United States $1.699B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.653B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.651B 0.00
Arcus Biosciences (RCUS) United States $1.633B 0.00
Viridian Therapeutics (VRDN) United States $1.611B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.588B 0.00
Myriad Genetics (MYGN) United States $1.581B 0.00
Travere Therapeutics (TVTX) United States $1.549B 0.00
Praxis Precision Medicines (PRAX) United States $1.451B 0.00
Gyre Therapeutics (GYRE) United States $1.431B 0.00
Novavax (NVAX) United States $1.426B 0.00
Kura Oncology (KURA) United States $1.355B 0.00
Upstream Bio (UPB) United States $1.344B 0.00
Vir Biotechnology (VIR) United States $1.322B 0.00
ANI Pharmaceuticals (ANIP) United States $1.293B 17.60
Arcutis Biotherapeutics (ARQT) United States $1.266B 0.00
Bicara Therapeutics (BCAX) United States $1.233B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.186B 0.00
Applied Therapeutics (APLT) United States $1.159B 0.00
ArriVent BioPharma (AVBP) United States $1.148B 0.00
Zymeworks (ZYME) United States $1.145B 0.00
Cogent Biosciences (COGT) United States $1.117B 0.00
MiMedx (MDXG) United States $1.107B 28.96
Immatics (IMTX) Germany $1.104B 0.00
Septerna (SEPN) $1.088B 0.00
Mesoblast (MESO) Australia $1.048B 0.00
89BIO (ETNB) United States $1.028B 0.00
CARGO Therapeutics (CRGX) United States $1.026B 0.00
Phathom Pharmaceuticals (PHAT) United States $1.005B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.993B 0.00
Rapport Therapeutics (RAPP) United States $0.976B 0.00
LENZ Therapeutics (LENZ) United States $0.964B 0.00
Prothena (PRTA) Ireland $0.952B 0.00
Castle Biosciences (CSTL) United States $0.932B 166.45
Cullinan Therapeutics (CGEM) United States $0.929B 0.00
Cytek Biosciences (CTKB) United States $0.927B 0.00
Pliant Therapeutics (PLRX) United States $0.912B 0.00
Erasca (ERAS) United States $0.887B 0.00
Neurogene (NGNE) United States $0.886B 0.00
Adaptive Biotechnologies (ADPT) United States $0.858B 0.00
Dianthus Therapeutics (DNTH) United States $0.853B 0.00
Tyra Biosciences (TYRA) United States $0.851B 0.00
Replimune (REPL) United States $0.850B 0.00
Liquidia Technologies (LQDA) United States $0.847B 0.00
Zenas BioPharma (ZBIO) United States $0.836B 0.00
AbCellera Biologics (ABCL) Canada $0.797B 0.00
Pacira BioSciences (PCRX) United States $0.796B 7.50
Anavex Life Sciences (AVXL) United States $0.784B 0.00
Avid Bioservices (CDMO) United States $0.782B 0.00
Immunome (IMNM) United States $0.780B 0.00
IGM Biosciences (IGMS) United States $0.773B 0.00
Annexon (ANNX) United States $0.764B 0.00
BioAge Labs (BIOA) United States $0.758B 0.00
Entrada Therapeutics (TRDA) United States $0.742B 12.47
Stoke Therapeutics (STOK) United States $0.735B 0.00
MBX Biosciences (MBX) United States $0.730B 0.00
Oric Pharmaceuticals (ORIC) United States $0.724B 0.00
Nuvation Bio (NUVB) United States $0.718B 0.00
Arbutus Biopharma (ABUS) United States $0.711B 0.00
Olema Pharmaceuticals (OLMA) United States $0.710B 0.00
CorMedix Inc (CRMD) United States $0.704B 0.00
Mineralys Therapeutics (MLYS) United States $0.698B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.690B 0.00
Humacyte (HUMA) United States $0.690B 0.00
Sana Biotechnology (SANA) United States $0.669B 0.00
Astria Therapeutics (ATXS) United States $0.667B 0.00
Abivax SA (ABVX) France $0.663B 0.00
Oculis Holding AG (OCS) Switzerland $0.659B 0.00
AnaptysBio (ANAB) United States $0.648B 0.00
Tectonic Therapeutic (TECX) United States $0.648B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Allogene Therapeutics (ALLO) United States $0.644B 0.00
CureVac (CVAC) Germany $0.636B 0.00
Emergent Biosolutions (EBS) United States $0.623B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.622B 0.00
Third Harmonic Bio (THRD) United States $0.616B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.613B 0.00
Sangamo Therapeutics (SGMO) United States $0.598B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.591B 0.00
ACELYRIN, INC (SLRN) United States $0.589B 0.00
Celcuity (CELC) United States $0.587B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.568B 0.00
Alumis (ALMS) United States $0.568B 0.00
Alector (ALEC) United States $0.563B 0.00
Pharming Group (PHAR) Netherlands $0.554B 0.00
REGENXBIO (RGNX) United States $0.553B 0.00
Q32 Bio (QTTB) United States $0.546B 0.00
Aura Biosciences (AURA) United States $0.540B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.529B 0.00
Foghorn Therapeutics (FHTX) United States $0.520B 0.00
Terns Pharmaceuticals (TERN) United States $0.513B 0.00
PureTech Health (PRTC) United States $0.499B 0.00
ChromaDex (CDXC) United States $0.496B 650.00
Prime Medicine (PRME) United States $0.492B 0.00
Contineum Therapeutics (CTNM) United States $0.473B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.472B 0.00
Absci (ABSI) United States $0.462B 0.00
GRAIL (GRAL) United States $0.450B 0.00
MeiraGTx Holdings (MGTX) United States $0.449B 0.00
GH Research (GHRS) Ireland $0.448B 0.00
Cartesian Therapeutics (RNAC) United States $0.444B 0.00
C4 Therapeutics (CCCC) United States $0.428B 0.00
Northwest Biotherapeutics (NWBO) United States $0.395B 0.00
Voyager Therapeutics (VYGR) United States $0.389B 25.46
Revance Therapeutics (RVNC) United States $0.388B 0.00
Alpha Teknova (TKNO) United States $0.382B 0.00
UniQure (QURE) Netherlands $0.380B 0.00
BioStem Technologies (BSEM) $0.379B 58.46
Jasper Therapeutics (JSPR) United States $0.371B 0.00
XOMA Royalty (XOMA) United States $0.362B 0.00
Sutro Biopharma (STRO) United States $0.359B 0.00
MaxCyte (MXCT) United States $0.357B 0.00
EnGene Holdings (ENGN) Canada $0.349B 0.00
Kamada (KMDA) Israel $0.345B 22.22
ITeos Therapeutics (ITOS) United States $0.339B 0.00
Codexis (CDXS) United States $0.332B 0.00
Design Therapeutics (DSGN) United States $0.330B 0.00
Artiva Biotherapeutics (ARTV) United States $0.318B 0.00
Tango Therapeutics (TNGX) United States $0.317B 0.00
AC Immune (ACIU) Switzerland $0.317B 0.00
Mersana Therapeutics (MRSN) United States $0.315B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.313B 0.00
Nautilus Biotechnology (NAUT) United States $0.313B 0.00
Rezolute (RZLT) United States $0.312B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.308B 0.00
Zura Bio (ZURA) United States $0.308B 0.00
TScan Therapeutics (TCRX) United States $0.306B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.303B 0.00
Poseida Therapeutics (PSTX) United States $0.299B 0.00
Biomea Fusion (BMEA) United States $0.296B 0.00
Atea Pharmaceuticals (AVIR) United States $0.295B 0.00
Urogen Pharma (URGN) United States $0.284B 0.00
Ocugen (OCGN) United States $0.284B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.283B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.282B 0.00
Abeona Therapeutics (ABEO) United States $0.277B 0.00
Fate Therapeutics (FATE) United States $0.276B 0.00
Prima BioMed (IMMP) Australia $0.270B 0.00
GENFIT S.A (GNFT) France $0.261B 0.00
Kodiak Sciences (KOD) United States $0.259B 0.00
Inozyme Pharma (INZY) United States $0.258B 0.00
Editas Medicine (EDIT) United States $0.258B 0.00
Climb Bio (CLYM) United States $0.254B 0.00
Anika Therapeutics (ANIK) United States $0.253B 0.00
Lifecore Biomedical (LFCR) United States $0.248B 0.00
Compass Therapeutics (CMPX) United States $0.248B 0.00
Precigen (PGEN) United States $0.247B 0.00
2seventy Bio (TSVT) United States $0.244B 0.00
Caribou Biosciences (CRBU) United States $0.243B 0.00
Opthea (OPT) Australia $0.240B 0.00
ATyr Pharma (ATYR) United States $0.236B 0.00
Amarin (AMRN) Ireland $0.236B 0.00
Inhibrx Biosciences (INBX) United States $0.235B 0.00
Solid Biosciences (SLDB) United States $0.235B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.234B 0.00
XBiotech (XBIT) United States $0.230B 0.00
Kyverna Therapeutics (KYTX) United States $0.228B 0.00
Molecular Partners AG (MOLN) Switzerland $0.228B 0.00
Eton Pharmaceuticals (ETON) United States $0.227B 0.00
Nkarta (NKTX) United States $0.225B 0.00
Trevi Therapeutics (TRVI) United States $0.224B 0.00
Cabaletta Bio (CABA) United States $0.219B 0.00
Fulcrum Therapeutics (FULC) United States $0.218B 0.00
Tenaya Therapeutics (TNYA) United States $0.218B 0.00
ScPharmaceuticals (SCPH) United States $0.210B 0.00
Nuvectis Pharma (NVCT) United States $0.209B 0.00
Semper Paratus Acquisition (TVGN) United States $0.208B 0.00
Bright Minds Biosciences (DRUG) United States $0.207B 0.00
CAMP4 Therapeutics (CAMP) United States $0.207B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.204B 0.00
Instil Bio (TIL) United States $0.201B 0.00
Gossamer Bio (GOSS) United States $0.199B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.196B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.192B 0.00
Greenwich LifeSciences (GLSI) United States $0.189B 0.00
Black Diamond Therapeutics (BDTX) United States $0.186B 0.00
DiaMedica Therapeutics (DMAC) United States $0.184B 0.00
Sagimet Biosciences (SGMT) United States $0.182B 0.00
Skye Bioscience (SKYE) United States $0.173B 0.00
Actuate Therapeutics (ACTU) United States $0.171B 0.00
Scilex Holding (SCLX) United States $0.169B 0.00
Adverum Biotechnologies (ADVM) United States $0.166B 0.00
PepGen (PEPG) United States $0.163B 0.00
Verastem (VSTM) United States $0.159B 0.00
Compugen (CGEN) Israel $0.159B 0.00
Akoya Biosciences (AKYA) United States $0.157B 0.00
Ventyx Biosciences (VTYX) United States $0.155B 0.00
Candel Therapeutics (CADL) United States $0.155B 0.00
Repare Therapeutics (RPTX) Canada $0.152B 0.00
Checkpoint Therapeutics (CKPT) United States $0.152B 0.00
Generation Bio (GBIO) United States $0.151B 0.00
Oncobiologics (OTLK) United States $0.150B 0.00
Innate Pharma S.A (IPHA) France $0.149B 0.00
Seer (SEER) United States $0.146B 0.00
Inventiva S.A (IVA) France $0.145B 0.00
Inovio Pharmaceuticals (INO) United States $0.144B 0.00
Cardiff Oncology (CRDF) United States $0.143B 0.00
Vigil Neuroscience (VIGL) United States $0.142B 0.00
Puma Biotechnology (PBYI) United States $0.141B 6.00
INmune Bio (INMB) United States $0.136B 0.00
FibroBiologics (FBLG) United States $0.131B 0.00
Adlai Nortye (ANL) Cayman Islands $0.131B 0.00
Elutia (ELUT) United States $0.129B 0.00
Rani Therapeutics Holdings (RANI) United States $0.129B 0.00
Seres Therapeutics (MCRB) United States $0.122B 0.00
PDS Biotechnology (PDSB) United States $0.121B 0.00
Allakos (ALLK) United States $0.121B 0.00
Coya Therapeutics (COYA) United States $0.120B 0.00
Adherex Technologies (FENC) United States $0.118B 0.00
Adagene (ADAG) China $0.117B 0.00
Alto Neuroscience (ANRO) United States $0.116B 0.00
Invivyd (IVVD) United States $0.115B 0.00
Benitec Biopharma (BNTC) United States $0.112B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.111B 0.00
23andMe Holding (ME) United States $0.110B 0.00
Adicet Bio (ACET) United States $0.108B 0.00
Annovis Bio (ANVS) United States $0.107B 0.00
Immunic (IMUX) United States $0.106B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.105B 0.00
X4 Pharmaceuticals (XFOR) United States $0.104B 0.00
Renovaro (RENB) United States $0.103B 0.00
BioAtla (BCAB) United States $0.102B 0.00
Genelux (GNLX) United States $0.101B 0.00
Rapt Therapeutics (RAPT) United States $0.101B 0.00
Werewolf Therapeutics (HOWL) United States $0.101B 0.00
Cellectis S.A (CLLS) France $0.098B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.098B 0.00
HilleVax (HLVX) United States $0.095B 0.00
Cidara Therapeutics (CDTX) United States $0.095B 0.00
Coherus BioSciences (CHRS) United States $0.094B 0.00
Ovid Therapeutics (OVID) United States $0.092B 0.00
BioHarvest Sciences (CNVCF) Canada $0.092B 0.00
InflaRx (IFRX) Germany $0.092B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.090B 0.00
I-Mab (IMAB) China $0.090B 0.00
Genenta Science S.p.A (GNTA) Italy $0.089B 0.00
Chimerix (CMRX) United States $0.089B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.088B 0.00
Clearside Biomedical (CLSD) United States $0.085B 0.00
CytomX Therapeutics (CTMX) United States $0.085B 6.41
VistaGen Therapeutics (VTGN) United States $0.085B 0.00
Ikena Oncology (IKNA) United States $0.085B 0.00
Agenus (AGEN) United States $0.084B 0.00
Cue Biopharma (CUE) United States $0.084B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
Oncolytics Biotech (ONCY) Canada $0.082B 0.00
Aileron Therapeutics (ALRN) United States $0.082B 0.00
Galena Biopharma (SLS) United States $0.079B 0.00
Bluebird Bio (BLUE) United States $0.079B 0.00
Aerovate Therapeutics (AVTE) United States $0.079B 0.00
Celularity (CELU) United States $0.078B 0.00
Boundless Bio (BOLD) United States $0.078B 0.00
CervoMed (CRVO) United States $0.077B 0.00
ALX Oncology Holdings (ALXO) United States $0.076B 0.00
TELA Bio (TELA) United States $0.076B 0.00
BeyondSpring (BYSI) United States $0.076B 0.00
MediciNova (MNOV) United States $0.075B 0.00
Quince Therapeutics (QNCX) United States $0.074B 0.00
ZIVO Bioscience (ZIVO) United States $0.073B 0.00
IO Biotech (IOBT) Denmark $0.072B 0.00
Spero Therapeutics (SPRO) United States $0.071B 3.22
Syros Pharmaceuticals (SYRS) United States $0.070B 0.00
Monopar Therapeutics (MNPR) United States $0.067B 0.00
Vor Biopharma (VOR) $0.066B 0.00
DBV Technologies S.A (DBVT) France $0.065B 0.00
Precision BioSciences (DTIL) United States $0.064B 0.00
Connect Biopharma Holdings (CNTB) United States $0.062B 0.00
Entera Bio (ENTX) Israel $0.062B 0.00
Omega Therapeutics (OMGA) United States $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
OnKure Therapeutics (OKUR) United States $0.059B 0.00
Affimed (AFMD) Germany $0.059B 0.00
Theratechnologies (THTX) Canada $0.058B 0.00
Immuneering (IMRX) United States $0.056B 0.00
Shattuck Labs (STTK) United States $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.054B 0.00
Kezar Life Sciences (KZR) United States $0.054B 0.00
Aadi Bioscience (AADI) United States $0.052B 0.00
Immix Biopharma (IMMX) United States $0.051B 0.00
Kronos Bio (KRON) United States $0.050B 0.00
Imunon (IMNN) United States $0.048B 0.00
Intensity Therapeutics (INTS) United States $0.045B 0.00
HOOKIPA Pharma (HOOK) United States $0.045B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.045B 0.00
Xilio Therapeutics (XLO) United States $0.044B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.043B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.042B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.042B 0.00
Rallybio (RLYB) United States $0.041B 0.00
Lantern Pharma (LTRN) United States $0.041B 0.00
VTv Therapeutics (VTVT) United States $0.041B 0.00
Clene (CLNN) United States $0.039B 0.00
Fortress Biotech (FBIO) United States $0.039B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
OKYO Pharma (OKYO) $0.038B 0.00
Passage Bio (PASG) United States $0.038B 0.00
Lexaria Bioscience (LEXX) Canada $0.037B 0.00
CalciMedica (CALC) United States $0.037B 0.00
NextCure (NXTC) United States $0.036B 0.00
Dare Bioscience (DARE) United States $0.036B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
KALA BIO (KALA) United States $0.035B 0.00
Dyadic (DYAI) United States $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
Aligos Therapeutics (ALGS) United States $0.033B 0.00
SAB Biotherapeutics (SABS) United States $0.032B 0.00
Promis Neurosciences (PMN) Canada $0.032B 0.00
Longeveron (LGVN) United States $0.032B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.030B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.030B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Opus Genetics (IRD) United States $0.029B 0.00
Ocean Biomedical (OCEA) United States $0.028B 0.00
BioXcel Therapeutics (BTAI) United States $0.028B 0.00
RenovoRx (RNXT) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Estrella Immunopharma (ESLA) United States $0.027B 0.00
Curis (CRIS) United States $0.026B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.025B 0.00
Femasys (FEMY) United States $0.025B 0.00
Pluri (PLUR) Israel $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Bionano Genomics (BNGO) United States $0.024B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.023B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.023B 0.00
Beyond Air (XAIR) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.022B 0.00
Spruce Biosciences (SPRB) United States $0.022B 0.00
Cyclo Therapeutics (CYTH) United States $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
Cognition Therapeutics (CGTX) United States $0.020B 0.00
UNITY Biotechnology (UBX) United States $0.020B 0.00
Aprea Therapeutics (APRE) United States $0.019B 0.00
Cadrenal Therapeutics (CVKD) United States $0.019B 0.00
Cara Therapeutics (CARA) United States $0.019B 0.00
LakeShore Biopharma (LSB) China $0.019B 0.00
BioAffinity Technologies (BIAF) United States $0.018B 0.00
Cocrystal Pharma (COCP) United States $0.018B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.018B 0.00
Synlogic (SYBX) United States $0.017B 0.00
GeoVax Labs (GOVX) United States $0.016B 0.00
Tenax Therapeutics (TENX) United States $0.016B 0.00
IN8bio (INAB) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
HCW Biologics (HCWB) United States $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
Evaxion Biotech (EVAX) Denmark $0.014B 0.00
Apollomics (APLM) United States $0.013B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Cingulate (CING) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
NKGen Biotech (NKGN) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.009B 0.00
Biora Therapeutics (BIOR) United States $0.009B 0.00
Galecto (GLTO) Denmark $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
TuHURA Biosciences (HURA) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Forte Biosciences (FBRX) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Bionomics (BNOX) Australia $0.007B 0.00
Aptose Biosciences (APTO) Canada $0.007B 0.00
Cyclerion Therapeutics (CYCN) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.007B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
Organovo Holdings (ONVO) United States $0.006B 0.00
Eterna Therapeutics (ERNA) United States $0.006B 0.00
TFF Pharmaceuticals (TFFP) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Portage Biotech (PRTG) $0.005B 0.00
BioCardia (BCDA) United States $0.005B 0.00
Dogwood Therapeutics (DWTX) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
GENPREX (GNPX) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) United States $0.004B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Pasithea Therapeutics (KTTA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Sunshine Biopharma (SBFM) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
NAYA Biosciences (NAYA) United States $0.003B 0.00
Citius Oncology (CTOR) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.001B 0.00
NeuBase Therapeutics (NBSE) United States $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Elevai Labs (ELAB) United States $0.000B 0.00
Windtree Therapeutics (WINT) United States $0.000B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00